Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
暂无分享,去创建一个
A. Giuliano | W. Ye | J. Pisegna | A. Bilchik | K. Ramming | M. Chung | M. J. Spirt | M. Spirt
[1] M. McCarter,et al. Role for Surgical Cytoreduction in Multimodality Treatments for Cancer , 2001, Annals of Surgical Oncology.
[2] K. Öberg. Interferon in the Management of Neuroendocrine GEP-Tumors , 2000, Digestion.
[3] D L Morton,et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. , 2000, Archives of surgery.
[4] D. Canes,et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? , 2000, Journal of the American College of Surgeons.
[5] D L Morton,et al. Radiofrequency ablation: a minimally invasive technique with multiple applications. , 1999, The cancer journal from Scientific American.
[6] L. Ellis,et al. Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .
[7] J. Ajani,et al. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Miller,et al. Therapeutic alternatives in metastatic neuroendocrine tumors. , 1998, Surgical oncology clinics of North America.
[9] D. Elias,et al. How I Do It: Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection , 1998, Journal of surgical oncology.
[10] M. Malago',et al. Treatment of liver metastases in patients with neuroendocrine tumors , 1998, Langenbeck's Archives of Surgery.
[11] S. Rogers,et al. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. , 1997, Surgery.
[12] A. Giuliano,et al. Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. , 1997, Surgery.
[13] T. Sarantou,et al. Cryosurgery causes a profound reduction in tumor markers in hepatoma and noncolorectal hepatic metastases. , 1997, The American surgeon.
[14] B. Dousset,et al. Metastatic Endocrine Tumors: Medical Treatment, Surgical Resection, or Liver Transplantation , 1996, World Journal of Surgery.
[15] K. Batts,et al. Hepatic resection for metastatic neuroendocrine carcinomas. , 1995, American journal of surgery.
[16] M. Clouse,et al. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. , 1994, Digestion.
[17] M. R. Aust,et al. Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. , 1994, Surgery.
[18] J. K. Martin,et al. The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas , 1994, Annals of Internal Medicine.
[19] J. Norton,et al. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. , 1992, Surgery.
[20] S. Lipsitz,et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. , 1992, The New England journal of medicine.
[21] E. Schrumpf,et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. , 1992, Surgery.
[22] D. Nagorney,et al. Cytoreductive hepatic surgery for neuroendocrine tumors. , 1990, Surgery.
[23] C. Moertel. Karnofsky memorial lecture. An odyssey in the land of small tumors. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] E. Wilander,et al. TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERON , 1986, The Lancet.
[25] L. Kvols,et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. , 1986, The New England journal of medicine.
[26] Galland Rb,et al. Carcinoid syndrome. Surgical management. , 1986 .
[27] E. Borden,et al. Depression of interferon production after A.L.S. treatment. , 1969, Lancet.